Johnson & Johnson shares rise despite $572m opioid ruling
Issued on: Modified:
Shares in Johnson & Johnson rose in after-hours trading on Monday, despite the company being hit with a $572 million penalty by an Oklahoma court for contributing to the state's opioid addiction crisis. The fine was lower than had been expected, and may prompt other firms to settle similar cases. Johnson & Johnson is appealing the decision. Also today, the French president has promised to compensate businesses in Biarritz affected by the G7 summit.